Dr. Jan Nolta heads he stem cell program for the UC Davis Health System and directs the Institute for Regenerative Cures. 

(Photo courtesy of UC Davis Health System)

Stemming Out

UC Davis researchers deliver lab innovations

Dr. Jan Nolta is a whirlwind of energy, and this July morning she is blitzing through UC Davis’ brand-new Institute for Regenerative Cures, a state-of-the-art lab where scientists and researchers are working on breakthrough discoveries and stem cell therapies.

Jul 31, 2010 Josh Brodesky
Vikram Janardhan, CEO, Insera Therapeutics; and Cary Adams, founder of, Proximal Ventures.

Stayin’ a Life

Will the health care overhaul affect investment in medical technology?

After four quarters of increasing venture investment, 2010 is off to a slow start. Venture capitalists invested $4.7 billion in the year’s first quarter, down from $5.2 billion in the fourth quarter of 2009, according to PricewaterhouseCoopers. The life sciences sector, including biotechnology and medical device industries, took the biggest hit with a 26 percent decline in venture investment over the previous quarter.

May 31, 2010 Christine Calvin

Equine Complex

Children find solace in horse-assisted therapy

Avery Benedict-Hall can’t talk, but when he slides onto a horse every Saturday morning at 11, his audience can hear the sound of his smile: clap, clap, clap. The 9-year-old has a host of neurological disorders, including cerebral palsy, autism and cortical visual impairment. Clapping is a soothing stimulant for many children with autism.

Dec 1, 2009 Stephanie Flores